Market News AIOpen the app

Eli Lilly 'Deserves' Stock Upside: Analyst

ResultsRead the original at Benzinga
Good for LLY

Eli Lilly beat sales and adjusted profit estimates, and raised its 2026 sales plan to $91 billion-$92 billion. It lowered its 2026 adjusted profit range to $35-$36 per share, but that still tops analysts' $34-per-share estimate.

LLY · Eli Lilly and Co.

AI read · Good for LLY

The AI's read

The higher sales plan reflects stronger demand, including interest from middle-income households and use of Medicare's weight-loss drug program. Lilly said these factors added about $10 billion to its initial estimate. The lower profit range is a real concern. Lilly linked the cut to research costs from recent acquisitions, and the new range still exceeds analysts' estimate.

Get alerts for LLY

Follow Eli Lilly and Co. (LLY) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for LLY
Free on the App Store and Google Play, or on the web.